ロード中...
TAOK3 is a MAP3K contributing to osteoblast differentiation and skeletal mineralization
Current anabolic drugs to treat osteoporosis and other disorders of low bone mass all have important limitations in terms of toxicity, contraindications, or poor efficacy in certain contexts. Addressing these limitations will require a better understanding of the molecular pathways, such as the mito...
保存先:
| 出版年: | Biochem Biophys Res Commun |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7494564/ https://ncbi.nlm.nih.gov/pubmed/32807497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2020.07.060 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|